title: Use of Saphenous Vein Bypass Grafts for Retrograde Recanalization of Coronary Chronic Total Occlusions: Insights From a Multicenter Registry.
abstract: BACKGROUND
  The use of saphenous vein grafts (SVGs) for retrograde native-vessel chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study.
  
  
  METHODS
  We retrospectively reviewed the medical records and coronary angiograms of retrograde CTO-PCI performed through an SVG at four United States institutions between 2012 and 2013.
  
  
  RESULTS
  During the study period, retrograde CTO-PCI was performed in 144 of 572 cases (25.2%) and retrograde CTO-PCI via SVG in 21 patients (14.6% of all retrograde cases). Mean age was 71 ± 7 years and 95.2% of the patients were men. The CTO target vessel was the right coronary (38%), circumflex (38%), and left anterior descending (24%) artery. Mean J-CTO score was 3.5 ± 1.0. The most common reentry technique was reverse controlled antegrade dissection and reentry. Technical and procedural success rates were 86% and 81%, respectively, with retrograde SVG-PCI attempts being successful in 67%. A major adverse cardiac event occurred in 2 patients (1 periprocedural myocardial infarction and 1 tamponade resulting in death). Median contrast volume, fluoroscopy time, and procedure time were 250 mL, 91.6 minutes, and 214 minutes, respectively. Two SVGs were coiled due to competitive flow after CTO recanalization.
  
  
  CONCLUSIONS
  Retrograde native-vessel CTO-PCI via SVG represents a small proportion of retrograde CTO-PCIs and was associated with high technical success rates, but may carry increased risk for complications.
authors.forename: Phuong-Khanh J
authors.initials: PK
authors.lastname: Nguyen-Trong
authors.forename: Khaldoon
authors.initials: K
authors.lastname: Alaswad
authors.forename: Dimitri
authors.initials: D
authors.lastname: Karmpaliotis
authors.forename: William
authors.initials: W
authors.lastname: Lombardi
authors.forename: J Aaron
authors.initials: JA
authors.lastname: Grantham
authors.forename: Nicholas
authors.initials: N
authors.lastname: Lembo
authors.forename: David
authors.initials: D
authors.lastname: Kandzari
authors.forename: Aris
authors.initials: A
authors.lastname: Karatasakis
authors.forename: Judit
authors.initials: J
authors.lastname: Karacsonyi
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Danek
authors.forename: Bavana V
authors.initials: BV
authors.lastname: Rangan
authors.forename: Michele
authors.initials: M
authors.lastname: Roesle
authors.forename: Colby R
authors.initials: CR
authors.lastname: Ayers
authors.forename: Craig A
authors.initials: CA
authors.lastname: Thompson
authors.forename: Subhash
authors.initials: S
authors.lastname: Banerjee
authors.affiliation: Dallas VA Medical Center (111A), 4500 South Lancaster Road, Dallas, TX 75216 USA. esbrilakis@gmail.com.
authors.forename: Emmanouil S
authors.initials: ES
authors.lastname: Brilakis
mesh_terms: D000368:Aged; D002908:Chronic Disease; D017023:Coronary Angiography; D054059:Coronary Occlusion / Q000175:diagnosis / Q000601:surgery*; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D012042:Registries; D012189:Retrospective Studies; D012501:Saphenous Vein / Q000637:transplantation*; D016896:Treatment Outcome